Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-055-6 | CAS number: 132-27-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
- Reference Type:
- secondary source
- Title:
- O-Phenylphenol and its Sodium and Potassium Salts: A Toxicological Assessment
- Author:
- Bomhard, E. M. et al.
- Year:
- 2 002
- Bibliographic source:
- Crit. Rev. Toxicol. 32(6):551-626
- Reference Type:
- secondary source
- Title:
- Analysis of Genotoxicity and the Carcinogenic Mode of Action for Ortho-Phenylphenol
- Author:
- Brusick, D.
- Year:
- 2 005
- Bibliographic source:
- Environ Mol Mutagen 45:460-481
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- (1984)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: New and Revised Health Effects Test Guidelines, October 1984 (U.S.) Environmental Protection Agency, Washington DC (PB 84-233295), HG - Gene Muta - Somatic Cells, October 1984
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Biphenyl-2-ol
- EC Number:
- 201-993-5
- EC Name:
- Biphenyl-2-ol
- Cas Number:
- 90-43-7
- Molecular formula:
- C12H10O
- IUPAC Name:
- 2-phenylphenol
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Preventol o extra, o-Phenylphenol, 1,1'-Biphenyl-2-ol
- Physical state: white crystalline solid
- Analytical purity: 99.9%
- Purity test date: 4 Jul 1989, approved 18 May 1991
- Lot/batch No.: 430 501-00 Pa. 18
Constituent 1
- Specific details on test material used for the study:
- - Storage condition of test material: refrigerator
Method
- Target gene:
- HPRT locus
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: CHO-WB1
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Ham's F12 medium supplemented with L-glutamine (1 mM), penicillin (50 U/mL), streptomycin (50 µg/mL) and FCS (final concentration 10%)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- Co-factor supplemented microsomal S9 homogenate from Aroclor 1254 induced male Wistar rats
- Test concentrations with justification for top dose:
- -S9: 6.25, 12.5, 25.0, 50.0, 75.0 and 100.0 µg/mL
+S9: 12.5, 25.0, 50.0, 75.0, 100.0 and 115.0 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Remarks:
- -S9: ethylmethanesulfonate 0.9 mg/mL; +S9: 7,12-dimethylbenzanthracene 20 µg/mL
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 5 h
- Expression time (cells in growth medium): 7 days
- Selection time (if incubation with a selection agent): 7 days
- Fixation time (start of exposure up to fixation or harvest of cells): 14 days
SELECTION AGENT (mutation assays): 6-thioguanine
NUMBER OF REPLICATIONS: 3 replicates
DETERMINATION OF CYTOTOXICITY
- Method: relative cloning efficiency - Evaluation criteria:
- - An assay will be considered positive if a dose-dependent and reproducible increase in mutant frequency is observed. It is desirable to obtain this dose-relationship for at least 3 doses. The mutagenic response should be at least twice that of the negative controls. If a reproducible increase greater than two times the minimum criterion is observed for a single dose near the highest testable concentration, the test article is also considered mutagenic.
- An assay will be considered equivocal if there is a no dose-dependency but one or more doses induce a mutant frequency which is considered significant and/or is at least twice that of the negative controls.
- An assay will be considered negative if none of the doses tested (for a range of applied concentrations which extends to toxicity causing about 30% survival or less) induces a reproducible mutant frequency which is considered significant. - Statistics:
- The number of mutations per 1 Mio cells will be governed by the Poisson distribution provided that the following assumptions are met, as in the case of mutation experiments such as the HGPRT-assay:
- The mean number of spontaneous mutations must be small relative to the maximum possible number of events per sampling units.
- An occurrence of the event must be independent from prior occurrences within the sampling unit.
A Poisson heterogeneity test is used to determine whether or not there are statistically significant increases in mutant frequency.
If the test is first taken as a global test with subsequent comparisons among less than s mean with s being the number of groups including tthe negative controls (provided the global test yielded a significant result), the type I error rate may be adjusted to account for the multiplicity tests.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: at 75 µg/mL and above (+/-S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: at concentrations >250 µg/mL (preliminary dilution trial)
RANGE-FINDING/SCREENING STUDIES: Based on the results of a preliminary cytotoxicity test, concentrations of 6.25-100 µg/mL (-S9) and 12.5-115 µg/mL (+S9) were selected for the mutation tests.
COMPARISON WITH HISTORICAL CONTROL DATA:
Historical control data are available for the negative, vehicle and positive controls and are based on the results of 24 experiments performed from June 1988 to December 1989.
- Negative control: 8.0±7.3 (range 0.6-33.5) (-S9); 6.2±5.7 (range 0.6-26.3) (+S9)
- Vehicle control (DMSO): 7.4±7.3 (range 0.2-31.3) (-S9); 7.1±6.2 (range 0.6-25.3) (+S9)
- Positive cotrols: 289.4±156.0 (range 49.7-769.2) (-S9, ethylmethanesulfonate); 99.7±65.2 (range 20.2-441.4) (+S9, 7,12-dimethylbenzanthracene)
The results of the negative and vehicle controls, both with and without metabolic activation, are within the range of the historical control data. This is also true for the positive control in the presence of S9 mix. The positive control results without metabolic activation (Trial 1 and 3) exceed the historical control data; however, this is considered to have no impact on the reliability of the test.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The highest dose tested both with and without metabolic activation was too cytotoxic to be examined and was therefore not cloned. Only in Trial 1 with metabolic activation, this respective test concentration could be evaluated.
ADDITIONAL INFORMATION ON MUTAGENICITY:
Statistically significant increases were noted in few samples treated with the test item. However, these statistically significant increases were either observed in the presence of strong cytotoxicity or could not be confirmed by the duplicate treatment of the respective trial. In any case, there was no clear dose-relationship. Thus, the test item can be concluded to be not mutagenic to CHO-WB1 cells under the conditions of this test.
Any other information on results incl. tables
Table 1: Results of the Mammalian Cell Gene Mutation Assay - 5 h Exposure - Without Metabolic Activation
Concentration [µg/mL] |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Trial 1 |
Trial 2 |
Trial 3 |
||||
Negative control # |
96.8 |
11.3 6.3 |
107.3 |
2.5 3.8 |
80.3 |
4.3 1.5 |
Vehicle control ## |
100.0 |
5.2 7.9 |
100.0 |
1.5 3.2 |
100.0 |
5.2 1.4 |
Positive control ### |
15.9 |
855.2* 547.3* |
11.2 |
511.8* 511.0* |
6.5 |
819.1* 842.4* |
6.25 |
85.0 |
6.5 8.0 |
79.7 |
6.5 0.0 |
78.8 |
6.7 4.1 |
12.5 |
84.5 |
7.1 9.8 |
76.6 |
3.7 2.3 |
97.1 |
4.0 7.7 |
25.0 |
83.6 |
3.5 7.2 |
37.8 |
13.2* 16.9* |
67.5 |
3.3 9.4* |
50.0 |
40.7 |
9.2 1.8 |
46.6 |
3.4 10.5* |
87.6 |
4.3 2.1 |
75.0 |
0.6 |
23.4* 0.0 |
2.2 |
1.1 0.9 |
31.4 |
1.3 2.8 |
100.0 |
n.c. |
n.c. |
n.c. |
# Negative control: culture medium
## Vehicle control: DMSO
### Positive control: ethylmethanesulfonate 0.9 mg/mL
n.c. = not cloned due to cytotoxicity
* Significant increase, p≤0.05
Table 2: Results of the Mammalian Cell Gene Mutation Assay - 5 h Exposure - With Metabolic Activation
Concentration [µg/mL] |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Survival to treatment [% of vehicle control] |
Mutants Frequency x 1E-06 |
Trial 1 |
Trial 2 |
Trial 3 |
||||
Negative control # |
102.5 |
2.2 2.0 |
122.9 |
0.9 1.8 |
114.5 |
3.1 1.0 |
Vehicle control ## |
100.0 |
2.1 2.3 |
100.0 |
1.8 1.7 |
100.0 |
1.7 2.1 |
Positive control ### |
85.0 |
48.9* 25.1* |
101.2 |
31.8* 22.2* |
145.3 |
41.2* 49.8* |
12.5 |
c |
102.6 |
8.1* 3.0 |
150.4 |
2.9 4.5 |
|
25.0 |
107.0 |
8.8* 1.5 |
107.3 |
2.7 11.2* |
159.8 |
0.7 1.8 |
50.0 |
111.3 |
2.5 4.2 |
125.7 |
7.8* 2.7 |
113.0 |
2.2 0.9 |
75.0 |
86.3 |
1.3 1.1 |
48.1 |
0.9 4.4 |
65.4 |
0.9 3.4 |
100.0 |
103.3 |
0.7 0.7 |
31.6 |
1.0 0.8* |
18.1 |
1.9 0.0 |
115.0 |
53.5 |
7.1 2.2 |
n.c. |
n.c. |
# Negative control: culture medium
## Vehicle control: DMSO
### Positive control: 7,12-dimethylbenzanthracene 20 µg/mL
n.c. = not cloned due to cytotoxicity
c = contaminated
* Significant increase, p≤0.05
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
